Sanara MedTech (SMTI)
(Real Time Quote from BATS)
$28.47 USD
+1.39 (5.13%)
Updated Aug 8, 2024 03:20 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Sanara MedTech Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4.44 | -8.09 | -7.99 | -4.45 | -2.84 |
Depreciation/Amortization & Depletion | 3.68 | 2.37 | 0.60 | 0.29 | 0.12 |
Net Change from Assets/Liabilities | -2.87 | 1.06 | -0.93 | -0.86 | 0.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.39 | -0.89 | 3.51 | 0.98 | 0.19 |
Net Cash From Operating Activities | -3.25 | -5.55 | -4.81 | -4.03 | -2.17 |
Property & Equipment | -0.26 | -0.15 | -0.17 | -0.54 | -0.18 |
Acquisition/ Disposition of Subsidiaries | -9.94 | -2.52 | 0.00 | 0.00 | 0.51 |
Investments | 0.00 | -0.25 | -4.53 | -1.10 | 0.00 |
Other Investing Activities | 0.00 | -0.60 | -0.58 | -1.10 | -1.52 |
Net Cash from Investing Activities | -10.21 | -3.51 | -5.28 | -2.74 | -1.20 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.91 | 0.00 | 28.94 | 0.04 | 10.00 |
Issuance (Repayment) of Debt | 9.69 | 0.00 | 0.00 | 0.58 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.96 | -0.63 | -0.64 | 0.00 | -0.20 |
Net Cash from Financing Activities | 9.64 | -0.63 | 28.30 | 0.62 | 9.80 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -3.81 | -9.69 | 18.20 | -6.16 | 6.44 |
Cash at Beginning of Period | 8.96 | 18.65 | 0.46 | 6.61 | 0.18 |
Cash at End of Period | 5.15 | 8.96 | 18.65 | 0.46 | 6.61 |
Diluted Net EPS | -0.52 | -1.00 | -1.08 | -0.76 | -1.32 |
Fiscal Year End for Sanara MedTech Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -1.80 | -4.44 | -4.18 | -3.08 |
Depreciation/Amortization & Depletion | NA | 1.11 | 3.68 | 2.58 | 1.58 |
Net Change from Assets/Liabilities | NA | -1.87 | -2.87 | -2.39 | -3.10 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.96 | 0.39 | 1.59 | 1.14 |
Net Cash From Operating Activities | NA | -1.59 | -3.25 | -2.40 | -3.46 |
Property & Equipment | NA | -0.07 | -0.26 | -0.21 | -0.04 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | -9.94 | -9.94 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.07 | -10.21 | -10.15 | -0.04 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.91 | 1.03 | 1.03 |
Issuance (Repayment) of Debt | NA | 0.00 | 9.69 | 9.69 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.66 | -0.96 | -0.90 | -0.43 |
Net Cash from Financing Activities | NA | -0.66 | 9.64 | 9.83 | 0.60 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -2.32 | -3.81 | -2.72 | -2.90 |
Cash at Beginning of Period | NA | 5.15 | 8.96 | 8.96 | 8.96 |
Cash at End of Period | NA | 2.83 | 5.15 | 6.24 | 6.06 |
Diluted Net EPS | NA | -0.21 | -0.03 | -0.13 | -0.22 |